New Regional Secretariat to Advance Leprosy Advocacy in Asia
Culion Sanitarium and General Hospital Medical Director Dr. Arturo Cunanan urged delegates to the Regional Assembly of Organisations of People Affected by Leprosy in Asia to "put our partnership beyond these walls" and act on the strategies discussed at the three-day conference. Credit: Ben Kritz/IPSBy Ben KritzMANILA, Mar 5 2019 (IPS)Organisations of people affected by leprosy in Asia have agreed to form a regional-level secretariat to support national advocacies and represent their collective agenda at a world conference to be held later this year.This was the most significant development to emerge from the Regional Assembly of Organisations of People Affected by Leprosy in Asia held in Manila from Mar. 3 to 5. The Coalition of Leprosy Advocates of the Philippines (CLAP) was selected by the delegates to serve as the first regional secretariat. Sasakawa Memorial Health Foundation (SMHF) Executive Director Dr. Takahiro Nanri requested that the first major initiative of the secretariat be the formulation by June of a “road map” encompassing the Assembly’s consensus agenda, which would then be used by the SMHF and it’s parent body the Nippon Foundation (TNF) to help develop the programme for the world leprosy conference to be held in September. SMHF and TNF convened the regional assembly in partnership with CLAP and the Culion Sanitarium and General Hospital (CSGH).From theory to practiseCSGH chief Dr. Arturo C. Cunanan told the delegates assem...
Abstract In Type II lepromatous reaction, there is exacerbation of humoral immunity, classified as Gell &Coombs Type III hypersensitivity reaction. It is more common in lepromatous borderline (LB) and lepromatous lepromatous (LL) patients. Our objective was to study the clinical and laboratorial expressions of lepromatous Type II reactions, establishing concordances between them, and for this the medical records of leprosy patients observed at the Clementino Fraga Filho University Hospital of the Federal University of Rio de Janeiro (HUCFF/UFRJ) were reviewed. There were a total of 358 leprosy cases over a per...
Publication date: 19–25 October 2019Source: The Lancet, Volume 394, Issue 10207Author(s): Pugazhenthan Thangaraju, Sajitha Venkatesan
In Reply We thank Dr Bishnoi and colleagues for their interest in our study and for sharing us with the current epidemic status of leprosy and the focus of the disease control activities in India.
To the Editor We congratulate Liu et al for their work involving proactive HLA screening to prevent dapsone hypersensitivity syndrome (DHS) in patients with leprosy. Herein, we describe the practical difficulties in translating this screening into clinical practice in India.
In this study, the inflammation noted in lesions of T1R is a different phenotype of Th17 which produce double positive IL-17A+IL17F+ and also contributes IL-17 producing neutrophils and thus would be useful for monitoring, diagnosis and treatment response before reactions episodes. PMID: 31629113 [PubMed - as supplied by publisher]
PMID: 31621065 [PubMed - as supplied by publisher]
C, Ramos AN Abstract The study aimed to analyze the magnitude and sociodemographic profile of leprosy cases linked to household contact networks with overlapping of the disease in two Brazilian municipalities (counties), one in the North and the other in the Northeast, from 2001 to 2014. This was a cross-sectional, descriptive, analytical study based on primary and secondary data from new leprosy cases in Picos, Piauí State, and Rolim de Moura, Rondônia State. "Overlapping" was defined as new cases with the occurrence of at least one more leprosy case in the individual's household contact ne...
Dr Neil Long Funtabulously Frivolous Friday Five 297 It's Friday. Boggle your brain with FFFF challenge and some old fashioned trivia. Funtabulously Frivolous Friday Five 297
More News: Cardiology | China Health | Conferences | Education | Heart | Hospitals | Indonesia Health | International Medicine & Public Health | Kiribati Health | Learning | Leprosy | Marketing | Nepal Health | Partnerships | Philippines Health | Politics | United Nations | Universities & Medical Training